NCT00234897已完成4 期
Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Abbott
- 入组人数
- 1,938
- 试验地点
- 2
- 主要终点
- Patient reported outcomes, clinical response indicators.
研究概览
简要总结
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
- •Subject, based on assessment of investigator, meets the definition of active RA
排除标准
- •Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
- •Female subject who is pregnant or breast-feeding or considering becoming pregnant
结局指标
主要结局
Patient reported outcomes, clinical response indicators.
次要结局
- Subject reported assessments of disease activity, physician reported assessments of disease activity, safety parameters, clinical response indicators.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabRheumatoid ArthritisPsoriatic ArthritisAnkylosing SpondylitisNCT01273519AbbVie (prior sponsor, Abbott)155
已完成
不适用
Real-World Outcome of Rheumatoid Arthritis Patients in Korea on AdalimumabRheumatoid ArthritisNCT02627924AbbVie91
已完成
不适用
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in TaiwanRheumatoid ArthritisNCT02616380AbbVie100
招募中
不适用
Adalimumab drug optimisation in rheumatoid arthritis using therapeutic drug monitoring (ADDORA): multi-centre open label randomised controlled trailRheumatoid arthritisNL-OMON26185Reade Rheumatology Research Institute267
已完成
不适用
Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRAModerate-to-severe Rheumatoid ArthritisNCT01117480AbbVie (prior sponsor, Abbott)1,013